April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Epiblast-Derived Skeletal Muscle Stem Cells Promote Eye Development
Author Affiliations & Notes
  • J. V. Gerhart
    Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
  • J. Elder
    Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania
  • J. Pfautz
    Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
  • K. DuPrey
    Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania
  • C. Neely
    Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
  • A. Menko
    Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
  • K. Knudsen
    Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
  • M. George-Weinstein
    Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania
  • Footnotes
    Commercial Relationships  J.V. Gerhart, None; J. Elder, None; J. Pfautz, None; K. DuPrey, None; C. Neely, None; A. Menko, None; K. Knudsen, None; M. George-Weinstein, None.
  • Footnotes
    Support  NIH Grant AR052326
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3213. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. V. Gerhart, J. Elder, J. Pfautz, K. DuPrey, C. Neely, A. Menko, K. Knudsen, M. George-Weinstein; Epiblast-Derived Skeletal Muscle Stem Cells Promote Eye Development. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3213.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The epiblast layer of the early embryo contains a subpopulation of skeletal muscle stem cells (e-skm stem cells) that express MyoD mRNA, the G8 antigen and Noggin, an inhibitor of bone morphogenetic proteins (BMPs). Ablation of e-skm stem cells in the epiblast results in protrusion of organs through the ventral body wall and eye malformations. The goals of this study were to: (1) determine the sites of incorporation of e-skm stem cells in the developing eye, (2) examine e-skm stem cells for expression of Noggin within ocular tissues, and (3) characterize the eye defects that arise when e-skm stem cells are ablated in the epiblast.

Methods: : E-skm stem cells were fluorescently labeled in the stage 2 chick embryo with a monoclonal antibody that binds to the G8 antigen. The distribution of e-skm stem cells in the developing eye was determined by epifluorescence microscopy. Expression of Noggin in e-skm stem cells was analyzed by in situ hybridization. E-skm stem cells were ablated in the epiblast by lysing G8 labeled cells with complement. Ablated embryos were supplemented with exogenous Noggin by implanting beads soaked in human recombinant Noggin. The eyes were examined in whole embryos and tissue sections.

Results: : E-skm stem cells were tracked into the anterior/lateral neural plate and adjacent ectoderm that form the optic cup and lens placode, respectively. In older embryos, Noggin expressing e-skm stem cells were found in the optic cup, lens and periocular mesenchyme. Ablation of e-skm stem cells in the epiblast produced eye defects of varying severity, including clinical anopthalmia, micropthalmia, aniridea, malformed lenses and optic cups, and retinal looping. Supplementation of ablated embryos with exogenous Noggin reduced the severity of eye defects.

Conclusions: : E-skm stem cells are required for normal eye development. Release of Noggin by e-skm stem cells may regulate BMP signaling in the lens, optic cup and periocular mesenchyme.

Keywords: development • cell-cell communication • pathology: experimental 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×